New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

One out of eight men develops prostate cancer. With the support from the Medical Research Future Fund (MRFF) Frontiers Initiative, the goal of the multidisciplinary multi-institutional ...

Nubia has launched the Nubia Tablet Pro, the company’s latest flagship gaming tablet, in China alongside the camera-centric Z70S Ultra smartphone. It is a cheaper alternative to flagship tablets ...

One of the children was undergoing cancer treatment and one of the mothers is pregnant. Both families had lived in the country for years and had ties to their communities, according to the ...

It almost led to a point where I was told by a few doctors that this could be prostate cancer, but it turned out it was a false alarm. Since then, I've been very, very careful in terms of getting ...

Bollywood playback singer Shaan, the voice behind chartbusters like Tanha Dil, Musu Musu Hasi, and Chand Sifarish, recently revealed that he had a prostate cancer scare back in 2020, which turned ...

New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study. The drug, ivonescimab, was approved for previously untreated patients with ...

BOOX has launched two 7-inch Android-based E Ink tablets with stylus support. The new BOOX Go 7 is priced at $249.99 and features a black-and-white E Ink Carta 1300 display. The BOOX Color Go 7 ...

And since the E Ink tablets ship with the Play Store, you can use any ebook storefront you like. The Boox Go Color 7 (Gen II) uses E Ink Kaleido 3 tech, also found in the Kobo Libra Colour and ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests. Prostate cancer has distinct genetic ...

The recovery timeline after prostate cancer surgery depends on the procedure a person undergoes and other factors. A person may have to stay in the hospital for a few days, followed by several ...

Don Bryant, Indiana resident, U.S. Army veteran, and prostate cancer survivor who received treatment with Pluvicto™ therapy in clinical trial Philip Low, Purdue Institute for Cancer Research member, ...